A new study is reviving hope that a twice-daily pill can slow down Alzheimer's in people whose genes put them at high risk ...
The Brighterside of News on MSN
New study finds 40Hz sensory stimulation may benefit some Alzheimer’s patients for years
A gentle flicker of light and a steady hum of sound might help slow the course of Alzheimer’s disease. That’s the idea behind ...
Health Canada recently authorized use of lecanemab, but experts say the drug is an incremental benefit, not a cure ...
Lecanemab, also known by the brand name Leqembi, is approved to treat mild cognitive impairment and early stages of Alzheimer's disease. Patients must have a documented presence of amyloid plaque in ...
A new drug to treat Alzheimer’s Disease has been approved by Health Canada and it is the first drug that targets an ...
A new vitamin K-based treatment could help replenish lost neurons in Alzheimer's patients, offering hope for slowing ...
On Real Possibilities with AARP Michigan, associate professor of translational neuroscience Dr. Scott Counts from Michigan ...
Alzheimer's disease is a progressive neurological disorder characterised by memory loss and cognitive decline, caused by ...
Arrowhead Pharmaceuticals, Inc. ( (ARWR)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert ...
Opinion
1don MSNOpinion
There’s no cure for Alzheimer’s, but this treatment works, and Europeans get it first
Cerezen is the first and only device certified under the new EU framework. The US FDA is a bit slower to approve it.
Farmington Hills, Michigan, Oct. 23, 2025 (GLOBE NEWSWIRE) -- “We made every effort to bring this treatment to U.S. patients first,” said Cerezen Founder and CEO Manoj Bhargava. “However, it seems ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback